Disclosure profile
Who’s trading NKE?
Open NKE on RobinhoodNIKE, Inc.
Every disclosed Congress and corporate-insider transaction in NKE (NIKE, Inc.): 43 trades from 19 politicians and executives, each AI-scored. Updated as new filings land.
Create a free account to open trades, see the full AI breakdown, and get live alerts when NKE is traded.
Create a free account →FilerActionAmountFiledScore
PARKER MARK GSEC Form 4——2026-08-173
Montagne AmySEC Form 4Sell$205k2026-08-114
NIKE, Inc. (NKE)SEC 8-K——2026-08-106
Friend MatthewSEC Form 4Sell$1032026-08-073
McCartney PhilipSEC Form 4Sell$22k2026-08-073
Alagirisamy VenkateshSEC Form 4Sell$37k2026-08-073
Leinwand RobertSEC Form 4Sell$34k2026-08-073
NIKE, Inc. (NKE) (CIK 0000320187)SEC Form 144Buy$205k2026-08-074
Friend MatthewSEC Form 4——2026-08-053
Alagirisamy VenkateshSEC Form 4—$35k2026-08-053
McCartney PhilipSEC Form 4—$212026-08-053
Leinwand RobertSEC Form 4—$17k2026-08-053
Montagne AmySEC Form 4—$24k2026-08-053
NIKE, Inc. (NKE) (CIK 0000320187)SEC Form 144Buy$37k2026-08-054
NIKE, Inc. (NKE) (CIK 0000320187)SEC Form 144Buy$22k2026-08-053
NIKE, Inc. (NKE) (CIK 0000320187)SEC Form 144Buy$34k2026-08-054
NIKE, Inc. (NKE) (CIK 0000320187)SEC Form 144Buy$102k2026-08-054
NIKE, Inc. (NKE)SEC 8-K——2026-06-236
NIKE, Inc. (NKE)SEC 8-K——2026-06-186
McCartney PhilipSEC Form 4——2026-06-123
Alagirisamy VenkateshSEC Form 4——2026-06-123
NIKE, Inc. (NKE) (CIK 0000320187)SEC Form 144Buy—2026-06-124
Hon. Kelly Louise MorrisonHouse PTRSell$1k2025-06-187
Hon. Kelly Louise MorrisonHouse PTRSell$1k2025-06-187
Hon. Julie JohnsonHouse PTRSell$1k2025-02-127
Hon. Thomas H. KeanHouse PTRSell$1k2024-10-156
Hon. Kathy ManningHouse PTRSell$1k2024-08-167
Hon. Kathy ManningHouse PTRSell$15k2024-08-168
Hon. Thomas H. KeanHouse PTRBuy$1k2024-07-207
Hon. Thomas H. KeanHouse PTRSell$1k2024-05-307
Hon. Earl BlumenauerHouse PTRBuy$15k2024-05-048
Hon. Dan NewhouseHouse PTRBuy$1k2024-04-257
Hon. Thomas H. KeanHouse PTRBuy$1k2024-03-187
Hon. Kathy ManningHouse PTRBuy$1k2024-02-067
Public-record disclosures (SEC Form 4 & Congressional PTRs). Research tool, not investment advice.
